Bcl-2 overexpression disrupts the morphology of PC12 cells through reduced ERK activation

Brain Research

Volumn 1112, Issue 1, 2006, Pages 46-55

  Mi, Zhiping ^a   Mirnics, Zeljka Korade ^a   Schor, Nina Felice ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

Actin; Bcl 2; Cell shape; Cytoskeleton; p ERK

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACTIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BCL 2; REGULATOR PROTEIN;

ANIMAL CELL; ARTICLE; CELL DISRUPTION; CELL SHAPE; CELL STRAIN; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITOR INTERACTION; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ACTINS; ANIMALS; BLOTTING, WESTERN; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GENE EXPRESSION; PC12 CELLS; PHALLOIDINE; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TIME FACTORS;

EID: 33748555549     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2006.07.017     Document Type: Article

References (36)

1. Alldridge L.C., and Bryant C.E. Annexin 1 regulates cell proliferation by disruption of cell morphology and inhibition of cyclin D1 expression through sustained activation of the ERK1/2 MAPK signal. Exp. Cell Res. 290 (2003) 93-107
2. Ashcroft M., Stephens R.M., Hallberg B., Downward J., and Kaplan D.R. The selective and inducible activation of endogenous PI 3-kinase in PC12 cells results in efficient NGF-mediated survival but defective neurite outgrowth. Oncogene 18 (1999) 4586-4597
3. Ben-Ze'ev A. Cytoskeletal and adhesion proteins as tumor suppressors. Curr. Opin. Cell Biol. 9 (1997) 99-108
4. Cowley S., Paterson H., Kemp P., and Marshall C.J. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77 (1994) 841-852
5. Del Bufalo D., Biroccio A., Leonetti C., and Zupi G. Bcl-2 overexpression enhances the metastatic potential of a human breast cancer line. FASEB J. 11 (1997) 947-953
6. Frisch S.M. Tumor suppression activity of adenovirus E1a protein: anoikis and the epithelial phenotype. Adv. Cancer Res. 80 (2001) 39-49
7. Fuchs E., and Karakesisoglou I. Bridging cytoskeletal intersections. Genes Dev. 15 (2001) 1-14
8. Gozdz A., Habas A., Jaworski J., Zielinska M., Albrecht J., Chlystun M., Jalili A., and Hetman M. Role of N-methyl-d-aspartate receptors in the neuroprotective activation of extracellular signal-regulated kinase 1/2 by cisplatin. J. Biol. Chem. 278 (2003) 43663-43671
9. Huang S.L., Ding B., Yu Q.S., and Guo Z.G. Effect of antisense mitogen-activated protein kinase oligonucleotides on rat vascular smooth muscle cell proliferation induced by EGF in vitro. Zhongguo Yao Li Xue Bao 19 (1998) 489-493
10. Klemke R.L., Cai S., Giannini A.L., Gallagher P.J., de Lanerolle P., and Cheresh D.A. Regulation of cell motility by mitogen-activated protein kinase. J. Cell Biol. 137 (1997) 481-492
11. Korb T., Schluter K., Enns A., Spiegel H.U., Senninger N., Nicolson G.L., and Haier J. Integrity of actin fibers and microtubules influences metastatic tumor cell adhesion. Exp. Cell Res. 299 (2004) 236-247
12. Li N., Batzer A., Daly R., Yajnik V., Skolnik E., Chardin P., Bar-Sagi D., Margolis B., and Schlessinger J. Guanine-nucleotide-releasing factor hSos1 binds to Grb2 and links receptor tyrosine kinases to Ras signalling. Nature 363 (1993) 85-88
13. Li L., Backer J., Wong A.S., Schwanke E.L., Stewart B.G., and Pasdar M. Bcl-2 expression decreases cadherin-mediated cell-cell adhesion. J. Cell. Sci. 116 (2003) 3687-3700
14. Liang Y., Yan C., and Schor N.F. Apoptosis in the absence of caspase 3. Oncogene 20 (2001) 6570-6578
15. Liang Y., Nylander K.D., Yan C., and Schor N.F. Role of caspase 3-dependent Bcl-2 cleavage in potentiation of apoptosis by Bcl-2. Mol. Pharmacol. 61 (2002) 142-149
16. Liang Y., Mirnics Z.K., Yan C., Nylander K.D., and Schor N.F. Bcl-2 mediates induction of neural differentiation. Oncogene 22 (2003) 5515-5518
17. Mandavilli B.S., Boldogh I., and Van Houten B. 3-nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells. Brain Res. Mol. Brain Res. 133 (2005) 215-223
18. Mi Z., Hong B., Mirnics Z.K., Tyurina Y.Y., Kagan V.E., Liang Y., and Schor N.F. Bcl-2-mediated potentiation of neocarzinostatin-induced apoptosis: requirement for caspase-3, sulfhydryl groups, and cleavable Bcl-2. Cancer Chemother. (2005) 1-11
19. Miyake H., Hara I., Yamanaka K., Gohji K., Arakawa S., and Kamidono S. Overexpression of Bcl-2 enhances metastatic potential of human bladder cancer cells. Br. J. Cancer 79 (1999) 1651-1656
20. Natalicchio A., Laviola L., De Tullio C., Renna L.A., Montrone C., Perrini S., Valenti G., Procino G., Svelto M., and Giorgino F. Role of the p66Shc isoform in insulin-like growth factor I receptor signaling through MEK/Erk and regulation of actin cytoskeleton in rat myoblasts. J. Biol. Chem. 279 (2004) 43900-43909
21. Olson M.F., Ashworth A., and Hall A. An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science 269 (1995) 1270-1272
22. Pang L., Sawada T., Decker S.J., and Saltiel A.R. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor. J. Biol. Chem. 270 (1995) 13585-13588
23. Park S.A., Park H.J., Lee B.I., Ahn Y.H., Kim S.U., and Choi K.S. Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells. Brain Res. Mol. Brain Res. 93 (2001) 18-26
24. Pawlak G., and Helfman D.M. Cytoskeletal changes in cell transformation and tumorigenesis. Curr. Opin. Genet. Dev. 11 (2001) 41-47
25. Rajalingam K., Wunder C., Brinkmann V., Churin Y., Hekman M., Sievers C., Rapp U.R., and Rudel T. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration. Nat. Cell Biol. 7 (2005) 837-843
26. Rescan C., Coutant A., Talarmin H., Theret N., Glaise D., Guguen-Guillouzo C., and Baffet G. Mechanism in the sequential control of cell morphology and S phase entry by epidermal growth factor involves distinct MEK/ERK activations. Mol. Biol. Cell 12 (2001) 725-738
27. Robbins D.J., Cheng M., Zhen E., Vanderbilt C.A., Feig L.A., and Cobb M.H. Evidence for a Ras-dependent extracellular signal-regulated protein kinase (ERK) cascade. Proc. Natl. Acad. Sci. U. S. A. 89 (1992) 6924-6928
28. Roovers K., and Assoian R.K. Effects of rho kinase and actin stress fibers on sustained extracellular signal-regulated kinase activity and activation of G(1) phase cyclin-dependent kinases. Mol. Cell Biol. 23 (2003) 4283-4294
29. Schoenwaelder S.M., and Burridge K. Bidirectional signaling between the cytoskeleton and integrins. Curr. Opin. Cell Biol. 11 (1999) 274-286
30. Seyfried J., Evert B.O., Schwarz C.S., Schaupp M., Schulz J.B., Klockgether T., and Wullner U. Gene dosage-dependent effects of bcl-2 expression on cellular survival and redox status. Free Radic. Biol. Med. 34 (2003) 1517-1530
31. Thomas S.M., DeMarco M., D'Arcangelo G., Halegoua S., and Brugge J.S. Ras is essential for nerve growth factor- and phorbol ester-induced tyrosine phosphorylation of MAP kinases. Cell 68 (1992) 1031-1040
32. Tsuji M., Inanami O., and Kuwabara M. Induction of neurite outgrowth in PC12 cells by alpha-phenyl-N-tert-butylnitron through activation of protein kinase C and the Ras-extracellular signal-regulated kinase pathway. J. Biol. Chem. 276 (2001) 32779-32785
33. Wang H.G., Rapp U.R., and Reed J.C. Bcl-2 targets the protein kinase Raf-1 to mitochondria. Cell 87 (1996) 629-638
34. Winter J.N., Andersen J., Reed J.C., Krajewski S., Variakojis D., Bauer K.D., Fisher R.I., Gordon L.I., Oken M.M., Jiang S., Jeffries D., and Domer P. BCL-2 expression correlates with lower proliferative activity in the intermediate- and high-grade non-Hodgkin's lymphomas: an Eastern Cooperative Oncology Group and Southwest Oncology Group cooperative laboratory study. Blood 91 (1998) 1391-1398
35. Wood K.W., Sarnecki C., Roberts T.M., and Blenis J. Ras mediates nerve growth factor receptor modulation of three signal-transducing protein kinases: MAP kinase, Raf-1, and RSK. Cell 68 (1992) 1041-1050
36. Yagi R., McBurney D., and Horton Jr. W.E. Bcl-2 positively regulates Sox9-dependent chondrocyte gene expression by suppressing the MEK-ERK1/2 signaling pathway. J. Biol. Chem. 280 (2005) 30517-30525